CareView Communications: extends credit agreement maturity to Jun 30, 2027

What happened As of Oct 7, 2026, CareView Communications, Inc. reported that it entered into a 17th Amendment to the Credit Agreement with PDL Investment Holdings, LLC (as assignee of PDL BioPharma, Inc.). The amendment, executed by the Company, the Borrower, the Lender, Steven G. Johnson (president and chief executive officer) and Dr. James R. Higgins (director), provides that the maturity date of the Credit Agreement is extended to Jun 30, 2027.

Key details

• The original Credit Agreement was dated Jun 26, 2015 and had been modified and amended on multiple prior occasions.
• The parties to the 17th Amendment include CareView Communications, Inc. (the Company and Borrower) and PDL Investment Holdings, LLC (the Lender).
• The amendment changes the Maturity Date to Jun 30, 2027.
• The report appears under Item 1.01 (entry into a material definitive agreement) and Item 2.03 (creation of a direct financial obligation).

Why it may matter The filing reports Item 1.01 (entry into a material definitive agreement) describing the 17th Amendment to the Credit Agreement and Item 2.03 (creation of a direct financial obligation) reflecting the extended maturity date. The filing does not show why the insider traded or why the company acted.